After a rough year in the trenches, Alnylam CEO John Maraganore and his team take a big cut in compensation
Alnylam CEO John Maraganore had a tough year in 2016. In early October the biotech’s stock plunged in the wake of his decision to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
